Tag: investment
-
Synthetic Bio Company Starts Up, Raises $53 Million
A start-up business that aims to apply principles of computer circuit design to biology and medicine in creating treatments for disease is raising $53 million in its first venture funding round.
-
Gut-Brain Therapies Biotech Raises $66M in New Funds
A 2 year-old biotechnology enterprise discovering new treatments for disease that harness signals between the gut and brain is raising $66 million its second venture financing round.
-
Cancer Analytics Company Acquired in $1.9B Deal
The global pharmaceutical company Roche is purchasing the cancer data management and analytics enterprise Flatiron Health in New York for $1.9 billion.
-
Report – Industry Pain, Addiction Drug Efforts Flagging
A report by a biotechnology industry organization says development efforts and financing for new drugs to treat pain and addiction are falling behind the health and safety needs of society.
-
Business Investment – Wealth Rules Backed By Science
You don’t want to be the kind of person who doesn’t use the facts to their advantage as it’s a sure-fire way to fail.
-
Neuro Therapy Company Spins-Off, Gains $20.8M Funding
A company developing treatments for cognitive impairment and Alzheimer’s disease is starting-up in Belgium, with a technology and financial backing from local and global businesses and investors.
-
Sanofi Buys Nano-Antibody Biotech in $4.8B Deal
Global drug maker Sanofi is acquiring a Belgian biotechnology company developing synthetic nanoscale therapeutic antibodies in a deal valued at $4.8 billion.
-
T-Cell Therapy Company Gains $100M in Venture Funds
A 2 year-old company developing treatments for cancer and other diseases that activate or suppress the immune system with genetically engineered T-cells is raising $100 million in its first venture funding round.
-
Blood Disorder Drug Maker Acquired in $11.6B Deal
The global pharmaceutical company Sanofi is buying Bioverativ Inc., a developer of biologics to treat hemophilia and other rare blood disorders.
-
Three Ways Tech Is Leveling The Playing Field Of Investing
If your idea of people that invest in the stock market is all cigars, pinstripe shirts and suspenders, you need to think again. The reason is new tech in this field means it’s no longer the domain of the filthy rich.